Recap: Summit Midstream Partners Q1 Earnings

Summit Midstream Partners (NYSE:SMLP) reported its Q1 earnings results on Friday, May 5, 2023 at 07:00 AM. Here’s…

Summit Midstream Partners (NYSE:SMLP) reported its Q1 earnings results on Friday, May 5, 2023 at 07:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Summit Midstream Partners missed estimated earnings by 1616.67%, reporting an EPS of $-1.82 versus an estimate of $0.12.

Revenue was up $16.37 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $1.73 which was followed by a 7.4% increase in the share price the next day.

Here’s a look at Summit Midstream Partners’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -1.30 -0.60 -1.06 -1.08
EPS Actual -3.03 -1.28 -9.53 1.32
Revenue Estimate 70.50M 68.40M 62.20M 82.73M
Revenue Actual 85.72M 88.68M 99.06M 96.13M

To track all earnings releases for Summit Midstream Partners visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Ultragenyx Reports Preliminary 2023 Revenue; Guidance For 2024 Revenue And Cash Usage; Pipeline Updates And 2024 Milestones; Sees FY23 Revenue $430-$435M Vs $435.9M Est.; Sees FY24 Revenue $500M-$530M Vs $523.86M Est.; Year-End 2023 Cash Balance Of ~$7…

Preliminary 2023 Total Revenue of $430 million to $435 million, Crysvita® Revenue of $325 million to $330 million and Dojolvi® revenue of $70 million to $71 million2024 expected Total Revenue guidance

RARE